MYSPHERA, a leading company in streamlining patient flows through new technologies, has received an investment from the EIC Fund to support its global expansion and become a leader in the Real-Time Location Systems (RTLS) market applied to the healthcare sector.
The investment by the EIC Fund, has attracted participation from venture capital funds SWANLAAB, Sabadell Venture Capital, ALIAD, and other private investors who were already involved in the company and amounted to 2.7 million euros in the first tranche.
MYSPHERA has demonstrated its ability to make healthcare processes more efficient through its real-time location solution. For example, in numerous European hospitals, its technology has increased the number of surgeries by over 16%, which has been studied and published by prestigious organizations such as the Royal College of Physicians in the United Kingdom. This is why the EIC Fund and the other investors see MYSPHERA as one of the key solutions to address waiting list problems in many of its public healthcare systems.
“We are very grateful to the EIC and our investors for their confidence in MYSPHERA,” said Salvador Vera, CEO of MYSPHERA. “Our goal is to improve the efficiency of healthcare processes and enable healthcare professionals to dedicate their entire working time to patients, freed from administrative or coordination tasks. This investment will allow us to continue developing our solutions and reaching more hospitals and healthcare centers worldwide.”
Marcin Nowak, representative of the European Investment Bank leading the investment on behalf of the EIC Fund, highlighted that “the investment in MYSPHERA is a demonstration of the EIC’s commitment to support innovation in the healthcare sector. We are convinced that MYSPHERA’s real-time location solution is a key tool to improve the efficiency of healthcare processes and reduce waiting times in many healthcare institutions.”
MYSPHERA has established itself as a leader in real-time location solutions for the healthcare field. With this investment, the Spanish company continues its path towards excellence and innovation, positioning itself as one of the key companies to improve the efficiency of healthcare systems worldwide.
About the EIC Fund:
The European Innovation Council Fund of the European Commission is an agnostic Fund: it invests across all technologies and verticals, and all EU countries and countries associated to Horizon Europe. It provides the investment component of the EIC Accelerator blended finance. The EIC Fund aims to fill a critical financing gap and its main purpose is to support companies in the development and commercialisation of disruptive technologies, bridging with and crowding in market players, and further sharing risk by building a large network of capital providers and strategic partners suitable for co-investments and follow-on funding. The Fund pays particular attention to the empowerment and support of female founders as well as the ambition to reduce the innovation divide among EU countries.